Hinge Health, Inc.
HNGE
$55.07
-$0.94-1.68%
NYSE
06/30/2025 | 03/31/2025 | ||||
---|---|---|---|---|---|
Revenue | 54.85% | 49.71% | |||
Total Other Revenue | -- | -- | |||
Total Revenue | 54.85% | 49.71% | |||
Cost of Revenue | 74.26% | -4.75% | |||
Gross Profit | 48.09% | 72.99% | |||
SG&A Expenses | 525.96% | 6.70% | |||
Depreciation & Amortization | -- | -- | |||
Other Operating Expenses | 327.52% | -- | |||
Total Operating Expenses | 570.33% | -3.02% | |||
Operating Income | -3,208.48% | 141.80% | |||
Income Before Tax | -4,483.98% | 564.95% | |||
Income Tax Expenses | -190.30% | 531.65% | |||
Earnings from Continuing Operations | -4,353.43% | 558.41% | |||
Earnings from Discontinued Operations | -- | -- | |||
Extraordinary Item & Accounting Change | -- | -- | |||
Minority Interest in Earnings | -- | -- | |||
Net Income | -4,353.43% | 558.41% | |||
EBIT | -3,208.48% | 141.80% | |||
EBITDA | -3,454.81% | 144.27% | |||
EPS Basic | -1,271.38% | 472.97% | |||
Normalized Basic EPS | -1,311.59% | 156.09% | |||
EPS Diluted | -1,271.38% | 472.48% | |||
Normalized Diluted EPS | -1,311.59% | 156.09% | |||
Average Basic Shares Outstanding | 224.74% | 22.91% | |||
Average Diluted Shares Outstanding | 224.74% | 22.91% | |||
Dividend Per Share | -- | -- | |||
Payout Ratio | -- | -- |